Clinical Trials Logo

Port Wine Stain clinical trials

View clinical trials related to Port Wine Stain.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00247299 Active, not recruiting - Port Wine Stain Clinical Trials

Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform

Start date: May 2005
Phase: N/A
Study type: Interventional

The Intense Pulsed Light (IPL) technology, by selective phototermolysis, is used for eliminating, among other application, benign vascular lesions and unwanted leg veins. Light energy heats the deeper structures of the skin. IPL devices provide a broad wavelength spectrum of 515 to 1200 nm and fluence from 10 to 40 J/cm at o.5-1 Hz.The light is focused by a reflector and then transmitted through various filters that cut off the lower wavelength range of the emitted light; therefore, only those wavelengths longer than these of the filters are transmitted. objectives: 1. evaluate and optimize the clinical performance of the Luminis ONE platform for each of the aforementioned clinical applications. 2. Reconfirm the parameter settings for each of the aforementioned clinical applications. 3. Confirm the user friendly design of the device, in aspects of software (user interface) and various technical operational features.